Global Automated Cell Culture Market Research Report—Forecast till 2027
出 版 商：Market Research Future
出版日期：2020/07/01
頁 數：148頁
文件格式：PDF
價 格：
USD 4,450 (Single-User License)
USD 6,250 (Global-User License)
USD 6,250 (Global-User License)
Global Automated Cell Culture Market Research Report—Forecast till 2027
Market Analysis
Global Automated Cell Culture Market was valued at USD 8,579.8 Million in 2019 and is expected to register a CAGR of 8.18% during the assessment period. These cells offer improved productivity and quality of cell lines without process change. The prime benefits of automated culture systems are minimized labour time, and less technical errors. The adoption of automated cell culture in various applications such as biopharmaceutical production, diagnostics, gene therapy, drug screening & development, toxicity testing, stem cell research, and tissue engineering & regenerative medicine is anticipated to increase the market growth.
However, the lack of awareness regarding advanced techniques and lack of skilled workforce may also pose a challenge for the automated cell culture market growth during the assessment period. Additionally, the increasing application for drug discovery & development and stem cell research are expected to create attractive growth during the research period. Moreover, the advanced applications such as the production of vaccines and gene therapy are estimated to boost the size of the automated cell culture market.
Market Segmentation
Global Automated Cell Culture Market has been categorized by Type, Product, Application and End User. The market, based on type, has been divided into modular automation and whole lab automation. The market, based on the product, has been bifurcated into consumables and vessels.
In terms of application segment, the global automated cell culture market has been segregated as biopharmaceutical production, diagnostics, gene therapy, drug screening and development, toxicity testing, stem cell research, tissue engineering & regenerative medicine and others. By end-user category, the global market has been classified into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research institutes, and cell banks.
Regional Analysis
Geographically, Global Automated Cell Culture Market has been categorized into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to lead the global automated cell culture market due to the largest market share of 42.8% in 2019. The regional market growth is driven by the existence of major manufacturers, increasing investment for manufacturers, and growing product launches, the presence of major automated cell culture players, and increasing number of diagnostic tests for various applications by major players in the region.
Europe is expected to share the second largest market of the global automated cell culture market followed by Asia Pacific. The market attributed to the rising presence of major manufacturers, increasing prevalence of chronic diseases, growing old age population, and advanced healthcare infrastructure in the region.
The Asia-Pacific region is anticipated to register the fastest growth owing to the increasing geriatric population, increasing oncological patients and the growing per capita expenditure.
Major Players
The Key Players in the Global Automated Cell Culture Market are Tecan Trading AG (Switzerland), Siemens Healthcare GmbH (Germany), Hitachi, Ltd (Japan), Thermo Fisher Scientific (US), Beckman Coulter, Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson, Sartorius Stedim Biotech Group (Germany), Hamilton Company (US), and Company (US) among others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Market Analysis
Global Automated Cell Culture Market was valued at USD 8,579.8 Million in 2019 and is expected to register a CAGR of 8.18% during the assessment period. These cells offer improved productivity and quality of cell lines without process change. The prime benefits of automated culture systems are minimized labour time, and less technical errors. The adoption of automated cell culture in various applications such as biopharmaceutical production, diagnostics, gene therapy, drug screening & development, toxicity testing, stem cell research, and tissue engineering & regenerative medicine is anticipated to increase the market growth.
However, the lack of awareness regarding advanced techniques and lack of skilled workforce may also pose a challenge for the automated cell culture market growth during the assessment period. Additionally, the increasing application for drug discovery & development and stem cell research are expected to create attractive growth during the research period. Moreover, the advanced applications such as the production of vaccines and gene therapy are estimated to boost the size of the automated cell culture market.
Market Segmentation
Global Automated Cell Culture Market has been categorized by Type, Product, Application and End User. The market, based on type, has been divided into modular automation and whole lab automation. The market, based on the product, has been bifurcated into consumables and vessels.
In terms of application segment, the global automated cell culture market has been segregated as biopharmaceutical production, diagnostics, gene therapy, drug screening and development, toxicity testing, stem cell research, tissue engineering & regenerative medicine and others. By end-user category, the global market has been classified into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research institutes, and cell banks.
Regional Analysis
Geographically, Global Automated Cell Culture Market has been categorized into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to lead the global automated cell culture market due to the largest market share of 42.8% in 2019. The regional market growth is driven by the existence of major manufacturers, increasing investment for manufacturers, and growing product launches, the presence of major automated cell culture players, and increasing number of diagnostic tests for various applications by major players in the region.
Europe is expected to share the second largest market of the global automated cell culture market followed by Asia Pacific. The market attributed to the rising presence of major manufacturers, increasing prevalence of chronic diseases, growing old age population, and advanced healthcare infrastructure in the region.
The Asia-Pacific region is anticipated to register the fastest growth owing to the increasing geriatric population, increasing oncological patients and the growing per capita expenditure.
Major Players
The Key Players in the Global Automated Cell Culture Market are Tecan Trading AG (Switzerland), Siemens Healthcare GmbH (Germany), Hitachi, Ltd (Japan), Thermo Fisher Scientific (US), Beckman Coulter, Inc. (US), F. Hoffmann-La Roche (Switzerland), Becton, Dickinson, Sartorius Stedim Biotech Group (Germany), Hamilton Company (US), and Company (US) among others.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 17
1.1.1 MARKET SYNOPSIS 18
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS 20
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 21
3.2 DATA MINING 21
3.3 SECONDARY RESEARCH 22
3.4 PRIMARY RESEARCH 23
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 GROWING RESEARCH AND DEVELOPMENT INITIATIVES IN THE PHARMACEUTICAL INDUSTRY 30
4.2.2 RISE IN ADOPTION OF LIQUID HANDLING SYSTEMS 30
4.2.3 INCREASING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES 31
4.3 RESTRAINTS 32
4.3.1 HIGH MAINTAINANCE COST 32
4.4 OPPORTUNITIES 33
4.4.1 RISING FOCUS ON REGENERATIVE MEDICINE 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 35
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 R&D AND DESIGNING 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION & SALES 37
5.2.4 POST-SALES MONITORING 37
5.3 IMPACT OF COVID-19 ON THE GLOBAL AUTOMATED CELL CULTURE MARKET 38
5.3.1 OVERVIEW 38
5.3.2 IMPACT ON CLINICAL TRIALS 38
5.3.3 IMPACT OF LABORATORY DEVELOPED TESTS (LDT) TO DIAGNOSE COVID-19 39
5.3.4 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING 39
6 GLOBAL AUTOMATED CELL CULTURE MARKET BY TYPE
6.1 OVERVIEW 42
6.2 MODULAR AUTOMATION 43
6.3 WHOLE LAB AUTOMATION 44
7 GLOBAL AUTOMATED CELL CULTURE MARKET BY PRODUCT
7.1 OVERVIEW 46
7.2 CONSUMABLES 47
7.3 VESSELS 49
8 GLOBAL AUTOMATED CELL CULTURE MARKET BY APPLICATION
8.1 OVERVIEW 51
8.2 BIOPHARMACEUTICAL PRODUCTION 52
8.3 TISSUE ENGINEERING & REGENERATIVE MEDICINE 53
8.4 DRUG SCREENING AND DEVELOPMENT 54
8.5 GENE THERAPY 55
8.6 STEM CELL RESEARCH 56
8.7 DIAGNOSTICS 57
8.8 TOXICITY TESTING 58
9 GLOBAL AUTOMATED CELL CULTURE MARKET BY END USER
9.1 OVERVIEW 60
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 61
9.3 RESEARCH INSTITUTES 62
9.4 HOSPITALS AND DIAGNOSTIC LABORATORIES 63
9.5 CELL BANKS 64
10 GLOBAL AUTOMATED CELL CULTURE MARKET BY REGION
10.1 OVERVIEW 66
10.2 AMERICAS 67
10.2.1 NORTH AMERICA 74
10.2.1.1 US 80
10.2.1.2 CANADA 84
10.2.2 LATIN AMERICA 87
10.3 EUROPE 91
10.3.1 WESTERN EUROPE 98
10.3.1.1 GERMANY 103
10.3.1.2 FRANCE 107
10.3.1.3 UK 111
10.3.1.4 ITALY 115
10.3.1.5 SPAIN 119
10.3.1.6 REST OF WESTERN EUROPE 123
10.3.2 EASTERN EUROPE 127
10.4 ASIA-PACIFIC 132
10.4.1 JAPAN 138
10.4.2 CHINA 142
10.4.3 INDIA 146
10.4.4 AUSTRALIA 150
10.4.5 SOUTH KOREA 154
10.4.6 REST OF ASIA-PACIFIC 158
10.5 MIDDLE EAST & AFRICA 162
10.5.1 MIDDLE EAST. 168
10.5.2 AFRICA 172
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 177
11.2 COMPETITIVE ANALYSIS 177
11.3 COMPETITIVE BENCHMARKING 178
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 178
11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL AUTOMATED CELL CULTURE MARKET 179
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 179
11.6.1 PRODUCT APPROVALS 179
11.6.2 ACQUISITIONS 181
11.6.3 AGREEMENTS/COLLABORATIONS 181
11.7 FINANCIAL MATRIX 182
12 COMPANY PROFILES
12.1 TECAN TRADING AG 183
12.1.1 COMPANY OVERVIEW 183
12.1.2 FINANCIAL OVERVIEW 184
12.1.3 PRODUCTS/SERVICES OFFERED 185
12.1.4 KEY DEVELOPMENTS 185
12.1.5 SWOT ANALYSIS 186
12.1.6 KEY STRATEGIES 186
12.2 SIEMENS 187
12.2.1 COMPANY OVERVIEW 187
12.2.2 FINANCIAL OVERVIEW 187
12.2.3 PRODUCTS/SERVICES OFFERED 189
12.2.4 KEY DEVELOPMENTS 189
12.2.5 SWOT ANALYSIS 190
12.2.6 KEY STRATEGIES 190
12.3 HITACHI, LTD 191
12.3.1 COMPANY OVERVIEW 191
12.3.2 FINANCIAL OVERVIEW 191
12.3.3 PRODUCTS/SERVICES OFFERED 192
12.3.4 KEY DEVELOPMENTS 192
12.3.5 SWOT ANALYSIS 193
12.3.6 KEY STRATEGIES 193
12.4 THERMO FISHER SCIENTIFIC INC. 194
12.4.1 COMPANY OVERVIEW 194
12.4.2 FINANCIAL OVERVIEW 194
12.4.3 PRODUCTS/SERVICES OFFERED 196
12.4.4 KEY DEVELOPMENTS 197
12.4.5 SWOT ANALYSIS 197
12.4.6 KEY STRATEGIES 197
12.5 SARTORIUS AG 198
12.5.1 COMPANY OVERVIEW 198
12.5.2 FINANCIAL OVERVIEW 198
12.5.3 PRODUCTS/SERVICES OFFERED 199
12.5.4 KEY DEVELOPMENTS 199
12.5.5 SWOT ANALYSIS 200
12.5.6 KEY STRATEGIES 200
12.6 HAMILTON COMPANY 201
12.6.1 COMPANY OVERVIEW 201
12.6.2 FINANCIAL OVERVIEW 201
12.6.3 PRODUCTS/SERVICES OFFERED 201
12.6.4 KEY DEVELOPMENTS 201
12.6.5 SWOT ANALYSIS 202
12.6.6 KEY STRATEGIES 202
12.7 BECKMAN COULTER, INC. 203
12.7.1 COMPANY OVERVIEW 203
12.7.2 FINANCIAL OVERVIEW 203
12.7.3 PRODUCTS/SERVICES OFFERED 203
12.7.4 KEY DEVELOPMENTS 203
12.7.5 SWOT ANALYSIS 204
12.7.6 KEY STRATEGIES 204
12.8 F. HOFFMANN-LA ROCHE LTD 205
12.8.1 COMPANY OVERVIEW 205
12.8.2 FINANCIAL OVERVIEW 205
12.8.3 PRODUCTS/SERVICES OFFERED 207
12.8.4 KEY DEVELOPMENTS 207
12.8.5 SWOT ANALYSIS 207
12.8.6 KEY STRATEGIES 207
12.9 MERCK KGAA 208
12.9.1 COMPANY OVERVIEW 208
12.9.2 FINANCIAL OVERVIEW 208
12.9.3 PRODUCTS/SERVICES OFFERED 209
12.9.4 KEY DEVELOPMENTS 209
12.9.5 SWOT ANALYSIS 210
12.9.6 KEY STRATEGIES 210
12.10 BECTON, DICKINSON AND COMPANY 211
12.10.1 COMPANY OVERVIEW 211
12.10.2 FINANCIAL OVERVIEW 212
12.10.3 PRODUCTS/SERVICES OFFERED 213
12.10.4 KEY DEVELOPMENTS 213
12.10.5 SWOT ANALYSIS 214
12.10.6 KEY STRATEGIES 214
13 APPENDIX
13.1 REFERENCES 215
13.2 RELATED REPORTS 215
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 17
1.1.1 MARKET SYNOPSIS 18
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 19
2.2 RESEARCH OBJECTIVE 19
2.3 LIST OF ASSUMPTIONS 20
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 21
3.2 DATA MINING 21
3.3 SECONDARY RESEARCH 22
3.4 PRIMARY RESEARCH 23
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24
3.5 FORECASTING TECHNIQUES 24
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25
3.6.1 BOTTOM-UP APPROACH 26
3.6.2 TOP-DOWN APPROACH 27
3.7 DATA TRIANGULATION 28
3.8 VALIDATION 28
4 MARKET DYNAMICS
4.1 OVERVIEW 29
4.2 DRIVERS 30
4.2.1 GROWING RESEARCH AND DEVELOPMENT INITIATIVES IN THE PHARMACEUTICAL INDUSTRY 30
4.2.2 RISE IN ADOPTION OF LIQUID HANDLING SYSTEMS 30
4.2.3 INCREASING PREVALENCE OF CANCER AND OTHER CHRONIC DISEASES 31
4.3 RESTRAINTS 32
4.3.1 HIGH MAINTAINANCE COST 32
4.4 OPPORTUNITIES 33
4.4.1 RISING FOCUS ON REGENERATIVE MEDICINE 33
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 34
5.1.1 BARGAINING POWER OF SUPPLIERS 35
5.1.2 BARGAINING POWER OF BUYERS 35
5.1.3 THREAT OF NEW ENTRANTS 35
5.1.4 THREAT OF SUBSTITUTES 35
5.1.5 INTENSITY OF RIVALRY 35
5.2 VALUE CHAIN ANALYSIS 36
5.2.1 R&D AND DESIGNING 37
5.2.2 MANUFACTURING 37
5.2.3 DISTRIBUTION & SALES 37
5.2.4 POST-SALES MONITORING 37
5.3 IMPACT OF COVID-19 ON THE GLOBAL AUTOMATED CELL CULTURE MARKET 38
5.3.1 OVERVIEW 38
5.3.2 IMPACT ON CLINICAL TRIALS 38
5.3.3 IMPACT OF LABORATORY DEVELOPED TESTS (LDT) TO DIAGNOSE COVID-19 39
5.3.4 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING 39
6 GLOBAL AUTOMATED CELL CULTURE MARKET BY TYPE
6.1 OVERVIEW 42
6.2 MODULAR AUTOMATION 43
6.3 WHOLE LAB AUTOMATION 44
7 GLOBAL AUTOMATED CELL CULTURE MARKET BY PRODUCT
7.1 OVERVIEW 46
7.2 CONSUMABLES 47
7.3 VESSELS 49
8 GLOBAL AUTOMATED CELL CULTURE MARKET BY APPLICATION
8.1 OVERVIEW 51
8.2 BIOPHARMACEUTICAL PRODUCTION 52
8.3 TISSUE ENGINEERING & REGENERATIVE MEDICINE 53
8.4 DRUG SCREENING AND DEVELOPMENT 54
8.5 GENE THERAPY 55
8.6 STEM CELL RESEARCH 56
8.7 DIAGNOSTICS 57
8.8 TOXICITY TESTING 58
9 GLOBAL AUTOMATED CELL CULTURE MARKET BY END USER
9.1 OVERVIEW 60
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 61
9.3 RESEARCH INSTITUTES 62
9.4 HOSPITALS AND DIAGNOSTIC LABORATORIES 63
9.5 CELL BANKS 64
10 GLOBAL AUTOMATED CELL CULTURE MARKET BY REGION
10.1 OVERVIEW 66
10.2 AMERICAS 67
10.2.1 NORTH AMERICA 74
10.2.1.1 US 80
10.2.1.2 CANADA 84
10.2.2 LATIN AMERICA 87
10.3 EUROPE 91
10.3.1 WESTERN EUROPE 98
10.3.1.1 GERMANY 103
10.3.1.2 FRANCE 107
10.3.1.3 UK 111
10.3.1.4 ITALY 115
10.3.1.5 SPAIN 119
10.3.1.6 REST OF WESTERN EUROPE 123
10.3.2 EASTERN EUROPE 127
10.4 ASIA-PACIFIC 132
10.4.1 JAPAN 138
10.4.2 CHINA 142
10.4.3 INDIA 146
10.4.4 AUSTRALIA 150
10.4.5 SOUTH KOREA 154
10.4.6 REST OF ASIA-PACIFIC 158
10.5 MIDDLE EAST & AFRICA 162
10.5.1 MIDDLE EAST. 168
10.5.2 AFRICA 172
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW 177
11.2 COMPETITIVE ANALYSIS 177
11.3 COMPETITIVE BENCHMARKING 178
11.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 178
11.5 MAJOR GROWTH STRATEGY IN THE GLOBAL AUTOMATED CELL CULTURE MARKET 179
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 179
11.6.1 PRODUCT APPROVALS 179
11.6.2 ACQUISITIONS 181
11.6.3 AGREEMENTS/COLLABORATIONS 181
11.7 FINANCIAL MATRIX 182
12 COMPANY PROFILES
12.1 TECAN TRADING AG 183
12.1.1 COMPANY OVERVIEW 183
12.1.2 FINANCIAL OVERVIEW 184
12.1.3 PRODUCTS/SERVICES OFFERED 185
12.1.4 KEY DEVELOPMENTS 185
12.1.5 SWOT ANALYSIS 186
12.1.6 KEY STRATEGIES 186
12.2 SIEMENS 187
12.2.1 COMPANY OVERVIEW 187
12.2.2 FINANCIAL OVERVIEW 187
12.2.3 PRODUCTS/SERVICES OFFERED 189
12.2.4 KEY DEVELOPMENTS 189
12.2.5 SWOT ANALYSIS 190
12.2.6 KEY STRATEGIES 190
12.3 HITACHI, LTD 191
12.3.1 COMPANY OVERVIEW 191
12.3.2 FINANCIAL OVERVIEW 191
12.3.3 PRODUCTS/SERVICES OFFERED 192
12.3.4 KEY DEVELOPMENTS 192
12.3.5 SWOT ANALYSIS 193
12.3.6 KEY STRATEGIES 193
12.4 THERMO FISHER SCIENTIFIC INC. 194
12.4.1 COMPANY OVERVIEW 194
12.4.2 FINANCIAL OVERVIEW 194
12.4.3 PRODUCTS/SERVICES OFFERED 196
12.4.4 KEY DEVELOPMENTS 197
12.4.5 SWOT ANALYSIS 197
12.4.6 KEY STRATEGIES 197
12.5 SARTORIUS AG 198
12.5.1 COMPANY OVERVIEW 198
12.5.2 FINANCIAL OVERVIEW 198
12.5.3 PRODUCTS/SERVICES OFFERED 199
12.5.4 KEY DEVELOPMENTS 199
12.5.5 SWOT ANALYSIS 200
12.5.6 KEY STRATEGIES 200
12.6 HAMILTON COMPANY 201
12.6.1 COMPANY OVERVIEW 201
12.6.2 FINANCIAL OVERVIEW 201
12.6.3 PRODUCTS/SERVICES OFFERED 201
12.6.4 KEY DEVELOPMENTS 201
12.6.5 SWOT ANALYSIS 202
12.6.6 KEY STRATEGIES 202
12.7 BECKMAN COULTER, INC. 203
12.7.1 COMPANY OVERVIEW 203
12.7.2 FINANCIAL OVERVIEW 203
12.7.3 PRODUCTS/SERVICES OFFERED 203
12.7.4 KEY DEVELOPMENTS 203
12.7.5 SWOT ANALYSIS 204
12.7.6 KEY STRATEGIES 204
12.8 F. HOFFMANN-LA ROCHE LTD 205
12.8.1 COMPANY OVERVIEW 205
12.8.2 FINANCIAL OVERVIEW 205
12.8.3 PRODUCTS/SERVICES OFFERED 207
12.8.4 KEY DEVELOPMENTS 207
12.8.5 SWOT ANALYSIS 207
12.8.6 KEY STRATEGIES 207
12.9 MERCK KGAA 208
12.9.1 COMPANY OVERVIEW 208
12.9.2 FINANCIAL OVERVIEW 208
12.9.3 PRODUCTS/SERVICES OFFERED 209
12.9.4 KEY DEVELOPMENTS 209
12.9.5 SWOT ANALYSIS 210
12.9.6 KEY STRATEGIES 210
12.10 BECTON, DICKINSON AND COMPANY 211
12.10.1 COMPANY OVERVIEW 211
12.10.2 FINANCIAL OVERVIEW 212
12.10.3 PRODUCTS/SERVICES OFFERED 213
12.10.4 KEY DEVELOPMENTS 213
12.10.5 SWOT ANALYSIS 214
12.10.6 KEY STRATEGIES 214
13 APPENDIX
13.1 REFERENCES 215
13.2 RELATED REPORTS 215
